Healthcare sector witnessed 12% decline in deal activity during week ended June 28, says GlobalData

The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 12% during the week ended June 28, 2020 compared to the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Though the healthcare sector has been relatively resilient compared to other sectors amid uncertainty and volatile market conditions due to the COVID-19 outbreak, deal activity in the sector has been inconsistent during the last few weeks and this is the second consecutive week of decline in deal activity.”

Deal activity has also remained inconsistent across geographies since the COVID-19 outbreak. While deal activity decreased in key markets such as the US, China, the UK and Canada during the week ended June 28, 2020 compared to the previous week, Japan and Australia witnessed growth.

Mergers and acquisitions (M&A), private equity, partnership and licensing agreement deals volume decreased by 16.7%, 44.4%, 32.6% and 18.2%, respectively, during the week ended June 28, 2020 compared to the previous week, while the number of equity offering and venture financing deals increased by 23.4% and 17.2%, respectively.


For more information
To gain access to our latest press releases: GlobalData Media Centre

Analysts available for comment. Please contact the GlobalData Press Office:
EMEA & Americas: +44 (0)207 936 6400
Asia-Pacific: +91 40 6616 6809


For expert analysis on developments in your industry, please connect with us on:
GlobalData | LinkedIn | Twitter

Editor’s notes

  • Quotes are provided by Aurojyoti Bose, Lead Analyst at GlobalData
  • The information is based on GlobalData’s Financial Deals Database
  • This press release was written using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts

About GlobalData
4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make timelier and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.

share this article...
Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

Not a robot? OK - prove it: *